Biotech3 years ago
Norbel Inversiones Divests 3% of Rovi’s Share Capital
Norbel Inversions, the investment vehicle of the López-Belmonte family, owners of the pharmaceutical company, wants to sell 1.6 million shares. The transaction will be carried out...